Logo image of VRA

VERA BRADLEY INC (VRA) Stock Fundamental Analysis

NASDAQ:VRA - Nasdaq - US92335C1062 - Common Stock - Currency: USD

2.02  -0.09 (-4.27%)

After market: 2.02 0 (0%)

Fundamental Rating

3

VRA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 48 industry peers in the Textiles, Apparel & Luxury Goods industry. While VRA has a great health rating, there are worries on its profitability. VRA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

VRA had negative earnings in the past year.
In the past year VRA has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: VRA reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: VRA reported negative operating cash flow in multiple years.
VRA Yearly Net Income VS EBIT VS OCF VS FCFVRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M

1.2 Ratios

VRA has a Return On Assets of -20.28%. This is amonst the worse of the industry: VRA underperforms 89.58% of its industry peers.
Looking at the Return On Equity, with a value of -34.75%, VRA is doing worse than 77.08% of the companies in the same industry.
Industry RankSector Rank
ROA -20.28%
ROE -34.75%
ROIC N/A
ROA(3y)-10.99%
ROA(5y)-5.57%
ROE(3y)-18.49%
ROE(5y)-9.46%
ROIC(3y)N/A
ROIC(5y)N/A
VRA Yearly ROA, ROE, ROICVRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

Looking at the Gross Margin, with a value of 50.23%, VRA is in line with its industry, outperforming 54.17% of the companies in the same industry.
VRA's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for VRA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.8%
GM growth 5Y-1.67%
VRA Yearly Profit, Operating, Gross MarginsVRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

More info and screens

7

2. Health

2.1 Basic Checks

VRA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, VRA has less shares outstanding
Compared to 5 years ago, VRA has less shares outstanding
VRA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
VRA Yearly Shares OutstandingVRA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
VRA Yearly Total Debt VS Total AssetsVRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 2.55 indicates that VRA is not a great score, but indicates only limited risk for bankruptcy at the moment.
VRA has a Altman-Z score of 2.55. This is comparable to the rest of the industry: VRA outperforms 41.67% of its industry peers.
VRA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.55
ROIC/WACCN/A
WACC10.25%
VRA Yearly LT Debt VS Equity VS FCFVRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 2.84 indicates that VRA has no problem at all paying its short term obligations.
VRA's Current ratio of 2.84 is fine compared to the rest of the industry. VRA outperforms 79.17% of its industry peers.
VRA has a Quick Ratio of 2.84. This is a bad value and indicates that VRA is not financially healthy enough and could expect problems in meeting its short term obligations.
VRA's Quick ratio of 0.95 is on the low side compared to the rest of the industry. VRA is outperformed by 62.50% of its industry peers.
Industry RankSector Rank
Current Ratio 2.84
Quick Ratio 0.95
VRA Yearly Current Assets VS Current LiabilitesVRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

More info and screens

1

3. Growth

3.1 Past

VRA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -220.37%.
Looking at the last year, VRA shows a very negative growth in Revenue. The Revenue has decreased by -21.00% in the last year.
Measured over the past years, VRA shows a decrease in Revenue. The Revenue has been decreasing by -5.56% on average per year.
EPS 1Y (TTM)-220.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-372.73%
Revenue 1Y (TTM)-21%
Revenue growth 3Y-11.71%
Revenue growth 5Y-5.56%
Sales Q2Q%-24.99%

3.2 Future

VRA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 45.22% yearly.
Based on estimates for the next years, VRA will show a very negative growth in Revenue. The Revenue will decrease by -12.46% on average per year.
EPS Next Y76.69%
EPS Next 2Y45.22%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-26.1%
Revenue Next 2Y-12.46%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
VRA Yearly Revenue VS EstimatesVRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
VRA Yearly EPS VS EstimatesVRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VRA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VRA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VRA Price Earnings VS Forward Price EarningsVRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VRA Per share dataVRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

VRA's earnings are expected to grow with 45.22% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.22%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

VRA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VERA BRADLEY INC

NASDAQ:VRA (5/30/2025, 4:02:55 PM)

After market: 2.02 0 (0%)

2.02

-0.09 (-4.27%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)03-12 2025-03-12/bmo
Earnings (Next)06-04 2025-06-04
Inst Owners72.57%
Inst Owner Change-1.89%
Ins Owners8.31%
Ins Owner Change-27.39%
Market Cap56.40M
Analysts80
Price Target4.08 (101.98%)
Short Float %17.48%
Short Ratio14.63
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-551.26%
Min EPS beat(2)-556.97%
Max EPS beat(2)-545.54%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-13.74%
Min Revenue beat(2)-19.17%
Max Revenue beat(2)-8.31%
Revenue beat(4)0
Avg Revenue beat(4)-12.06%
Min Revenue beat(4)-19.17%
Max Revenue beat(4)-8.31%
Revenue beat(8)0
Avg Revenue beat(8)-8.52%
Revenue beat(12)2
Avg Revenue beat(12)-6.09%
Revenue beat(16)3
Avg Revenue beat(16)-4.76%
PT rev (1m)0%
PT rev (3m)-36%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-157.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-36.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-29.55%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.15
P/FCF N/A
P/OCF N/A
P/B 0.32
P/tB 0.32
EV/EBITDA N/A
EPS(TTM)-0.65
EYN/A
EPS(NY)-0.15
Fwd EYN/A
FCF(TTM)-0.88
FCFYN/A
OCF(TTM)-0.51
OCFYN/A
SpS13.32
BVpS6.41
TBVpS6.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.28%
ROE -34.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.23%
FCFM N/A
ROA(3y)-10.99%
ROA(5y)-5.57%
ROE(3y)-18.49%
ROE(5y)-9.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.8%
GM growth 5Y-1.67%
F-Score3
Asset Turnover1.21
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 34.24%
Cap/Sales 2.79%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.84
Quick Ratio 0.95
Altman-Z 2.55
F-Score3
WACC10.25%
ROIC/WACCN/A
Cap/Depr(3y)37.76%
Cap/Depr(5y)36.59%
Cap/Sales(3y)1.74%
Cap/Sales(5y)1.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-220.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-372.73%
EPS Next Y76.69%
EPS Next 2Y45.22%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-21%
Revenue growth 3Y-11.71%
Revenue growth 5Y-5.56%
Sales Q2Q%-24.99%
Revenue Next Year-26.1%
Revenue Next 2Y-12.46%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-277.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year117.75%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-155.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-129.38%
OCF growth 3YN/A
OCF growth 5YN/A